Numab Therapeutics AG – Trademark Portfolio
Entity Type: 25
Numab Therapeutics AG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NUMAB and LAMBDA-CAP.
Einsiedlerstrasse 34
CH-8820 Wädenswil
Showing of trademarks Trademarks
Trademark Classifications
Numab Therapeutics AG's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Numab Therapeutics AG have?
Numab Therapeutics AG has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Numab Therapeutics AG file in?
Numab Therapeutics AG files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Numab Therapeutics AG's most well-known trademarks?
Numab Therapeutics AG's registered trademark portfolio includes well-known marks such as NUMAB and LAMBDA-CAP. These are among 2 currently registered trademarks in the portfolio.
What is Numab Therapeutics AG's trademark registration success rate?
Numab Therapeutics AG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.